Literature DB >> 14023264

Initial clinical studies with vincristine.

G COSTA, M M HRESHCHYSHYN, J F HOLLAND.   

Abstract

Entities:  

Keywords:  ANTIBIOTICS; ANTINEOPLASTIC AGENTS

Mesh：

Substances：

Year:  1962        PMID： 14023264

Source DB:  PubMed          Journal:  Cancer Chemother Rep        ISSN： 0069-0112


× No keyword cloud information.
  7 in total

1.  MICONIDINE acetate, a new selective and cytotoxic compound with synergic potential, induces cell cycle arrest and apoptosis in leukemia cells.

Authors:  Mariana Franzoni Maioral; Natália Marceli Stefanes; Álisson Bigolin; Gabriele Andressa Zatelli; Ana Cláudia Philippus; Miriam de Barcellos Falkenberg; Maria Cláudia Santos-Silva
Journal:  Invest New Drugs       Date:  2018-12-19       Impact factor: 3.850

Review 2.  Chemotherapy in colorectal cancer.

Authors:  T J McElwain
Journal:  Proc R Soc Med       Date:  1973-12

3.  Death from paralytic ileus following vincristine therapy.

Authors:  P J Toghill; J D Burke
Journal:  Postgrad Med J       Date:  1970-05       Impact factor: 2.401

4.  Coma associated with vincristine therapy.

Authors:  J A Whittaker; D H Parry; C Bunch; D J Weatherall
Journal:  Br Med J       Date:  1973-11-10

5.  VINCRISTINE IN THE TREATMENT OF NEOPLASTIC DISEASE.

Authors:  D M WHITELAW; H S KIM
Journal:  Can Med Assoc J       Date:  1964-06-20       Impact factor: 8.262

6.  An investigation of the mouse as a model for vincristine toxicity.

Authors:  S D Harrison
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

7.  Treatment of metastatic testicular tumours with bleomycin, etoposide, cisplatin and vincristine (BEPV).

Authors:  B A Price; N H Peters
Journal:  J R Soc Med       Date:  1992-11       Impact factor: 18.000
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.